Skip the surgery and pop the placebo, writes cheeky surgeon-author

Any surgery carries risk, which is why decisions to put patients under the knife should be carefully considered. However, one surgeon is calling attention to the fact that some common procedures end up being about as effective as a placebo procedure would have been—and the placebo would have cost a lot less while doing the patient zero harm.

Australian orthopedic surgeon and professor Ian Harris, also known as “Dr. Skeptic,” makes the case in a new book titled Surgery, The Ultimate Placebo: A Surgeon Cuts through the Evidence.

With his blog as his medium, Dr. Harris has taken it upon himself to review his own book. 

The review may be somewhat tongue in cheek, but the book sounds genuinely intriguing.

 

 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”